Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-10-29

Clinical Trial Update: ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating ShuntCheck for detecting shunt obstruction in Normal Pressure Hydrocephalus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NeuroDx Development | Conditions: Normal Pressure Hydrocephalus | Phase 4 | Status: WITHDRAWN